Simulations Plus Wins Cooperative Agreement with FDA
September 15, 2014
LANCASTER, Calif.-- Simulations Plus, Inc. (SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that it has been notified by the U.S. Food and Drug Administration (FDA) that the company has been awarded a $200,000 cooperative agreement to develop improved modeling and simulation capabilities for dosage forms designed [...]
COMPLETE, AUTOMATED ASTM D2983 SAMPLE CONDITIONING AND TESTING FROM CANNON INSTRUMENT COMPANY
September 15, 2014
State College, Pa. - CANNON Instrument Company introduces the first fully automated Thermoelectric Sample Conditioner (TESC) System for ASTM D2983. Incorporating a Brookfield® DV2T digital viscometer and thermoelectrically controlled sample chamber, the TESC System automates the entire conditioning and testing process, including preheating, room temperature stabilization, cooling of the sample to test temperature, and testing [...]
September 12, 2014
Albuquerque, NM -- Sandia Biotech, Inc. announced today that the company has signed an exclusive option agreement with STC.UNM (STC) for a technology developed by researchers at the University of New Mexico (UNM) in Albuquerque, New Mexico, and Queen Mary University of London in London, England. The group of technologies, called the Recombinant Fluorescent Antibody [...]
Agilent Technologies to Introduce Next-Generation UHPLC System at Analytica China on Sept. 23
September 11, 2014
SANTA CLARA, Calif.-– Agilent Technologies Inc. (NYSE: A) today announced it will introduce its latest innovation in ultra-high-performance liquid chromatography (UHPLC) on Sept. 23 at Analytica China, the international trade fair for laboratory technology, analysis, biotechnology and diagnostics held in Shanghai. “We are pleased to introduce our newest UHPLC solution at this important scientific event,” [...]
September 11, 2014
MOORESTOWN, N.J.-- Denton Vacuum, LLC, a leading manufacturer of thin film technology products, has introduced Vitua, the first automated TEM sample preparation system specifically designed and characterized for high resolution rotary shadow casting of large organic molecules. TEM organic molecule imaging presents unique challenges. Small samples, such as DNA or complex proteins, are difficult to [...]
Waters Unveils Global Mass Spectrometry Headquarters in the UK’s North West
September 11, 2014
WILMSLOW, U.K.-- Waters Corporation (NYSE: WAT) today celebrated the official opening of its new, custom-built mass spectrometry headquarters in Wilmslow, UK, confirming the company's commitment to innovation and the expanded usage of mass spectrometry. The facility has been designed and equipped to accelerate innovation in the field of mass spectrometry – a sophisticated analytical laboratory [...]
BGI, Imperial College London and Waters Corporation sign framework agreement
September 11, 2014
On September 11, 2014, BGI, Imperial College London and Waters Corporation signed a framework agreement in Shenzhen, China. Liangyu Zhang, CEO of Greater China of Waters Corporation, Vince Gao, CEO of BGI Heath, and representatives of Imperial College London attended the signing ceremony. The collaboration brings together three of the leading scientific groups in the [...]
Xylem Inc. named to Dow Jones Sustainability Index for North America for the third consecutive year
September 11, 2014
RYE BROOK, N.Y. -- Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today that it has been named to the Dow Jones Sustainability North America Index for the third consecutive year in recognition of its ongoing sustainability initiatives. Xylem is one of 140 [...]
September 11, 2014
ALAMEDA, Calif. -- BioTime, Inc. (NYSE MKT: BTX) announced that its subsidiary Asterias Biotherapeutics, Inc. (OTCBB: ASTY) has reached an agreement with Cancer Research UK and Cancer Research Technology (CRT), the charity’s development and commercialization arm, to conduct a clinical trial of Asterias’ novel immunotherapy treatment AST-VAC2 in subjects with non-small cell lung cancer. AST-VAC2 [...]
Corning Announces New Agreement with BioLamina
September 11, 2014
CORNING, N.Y. -– Corning Incorporated (NYSE: GLW) today announced it has entered into an agreement with BioLamina to manufacture and package the Recombinant Laminin-521 (rLaminin-521) pluripotent stem-cell and neural stem-cell growth matrix. The collaboration will augment Corning Life Sciences’ industry-leading portfolio of defined coating substrates and extend the availability of this product to research labs [...]

